← Back
Opko Health
OPK · listed on Nasdaq · worth $1.13 billion
$1.63
+0.62% on Oct 28
33 insider buys in the last year, $3.19 million in all. None in the last two weeks.
Green dot = an insider boughtA number = that many on nearby days · click a mark to see who, or read the filing
The shares anyone can buy and sell, leaving out those held by insiders and big long-term owners.
323.7M shares
43% of all shares
Shares borrowed and sold by investors who expect the price to drop.
Company insiders
In the last year, one insider bought Opko Health stock and none sold.
How each buyer's earlier purchases went: the stock about six months later, beside the S&P 500 over the same days. Purchases planned in advance are left out. Past results, not a forecast.
CEO & Chairman
Phillip Frost MD et al
Bought $281.9K on Nov 20, 2025 — 211,948 shares at $1.33, held through a trust or family, 0.1% of what they now own.
1 of 2 earlier purchases did better than the S&P 500
Big investors
People and funds that reported owning 5% or more of Opko Health, newest first.
Filed by someone who owns 5% or more and may try to influence how the company is run. · updateFrost Phillip MD ET AL34.1%Jul 1
All reports
Every insider trade and SEC report we hold for Opko Health.
Newest first
ReportedTradeInsiderOf their holdingShares @ priceValue
Nov 21, 2025BoughtPhillip Frost MD et al10%Nov 21, 2025 · CEO & Chairman+0.1%via a trust or family192,870 @ $1.34$257.5K
Nov 21, 2025BoughtPhillip Frost MD et al10%Nov 21, 2025 · CEO & Chairman+0.1%via a trust or family191,490 @ $1.33$254.7K
Nov 21, 2025BoughtPhillip Frost MD et al10%Nov 21, 2025 · CEO & Chairman+0.0%via a trust or family89,375 @ $1.33$118.4K
Nov 21, 2025BoughtPhillip Frost MD et al10%Nov 21, 2025 · CEO & Chairman+0.0%via a trust or family3,894 @ $1.32$5.1K
Nov 21, 2025BoughtPhillip Frost MD et al10%Nov 21, 2025 · CEO & Chairman+0.0%via a trust or family102,371 @ $1.30$133.1K
29 more with Pro →Analysts, earnings and news
Analysts' price target
$4.38 average
4 analysts
Analysts' opinions, which tend to run optimistic. Not our forecast or advice.
Profit vs what was expected
3 of 4 quarters above
Q1 '26−$0.07 a share−$0.00
Q4 '25−$0.04 a share+$0.03
Q3 '25$0.03 a share+$0.07
Q2 '25−$0.08 a share+$0.02